(EMAILWIRE.COM, August 27, 2019 ) Factors driving the growth of this Biobanking Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development.

The equipment segment is estimated to account for the largest share of the market. This is primarily attributed to the increasing number of biobanks and rising number of bio samples around the world, due to which the demand for equipment remains high.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

The Biobanking Market report provides insights on the following pointers:

· Biobanking Penetration: Comprehensive information on the product portfolios of the top players in the biobanking market

· Biobanks Market Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the biobanking market

· Biobanking Market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the biobanking market

· Biobanking Development: Comprehensive information about emerging markets. This report analyzes the market for various biobanking products across geographies

· Biobanks Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biobanking market

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/biobanking-devices.asp

Regenerative medicine applications for biobanking market will drive the market

Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.

Major Biobanking Market Developments

• In 2017, Brooks Automation, Inc. (U.S.) launched BioStore IIIv, BioStudies Biobank Data Management, FluidX, IntelliXcap Decapper systems to strengthen its product portfolio in biobanking segment.

• In 2016, Thermo Fisher Scientific Inc. (U.S.) entered into a partnership with Hamilton Storage (U.S.) to strengthened Thermo Fisher’s presence in the market.

• In 2015, Panasonic Healthcare Holdings (Japan) launched MDF-DU900V VIP -86°C Upright Freezer.

Major Key Players Operating the Biobanking Market:

include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.).